Navigation Links
Trade in Medical Technology

Spherix Reports First Quarter 2009 Earnings

... late-2010 trade shows/investor conferences: Ohio ... health sciences consulting services. trade shows Spherix Consulting has and will be ... 2,029,352 1,894,434 trade accounts receivable 189,617 ...

Physicians' Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease

... for Responsible Nutrition (CRN), the leading trade association representing the dietary supplement ... founded in 1973, is a Washington, D.C.-based trade association representing dietary ... more than 30 peer-reviewed papers, abstracts, trade journal articles and industry position papers. ...

38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty

... architecture debate, debt cancellation processes, trade negotiations and public ... of social movements, International NGOs, trade unions, community groups, women's organizations, ... and the fulfilment of human rights; trade justice; more and better aid; debt cancellation ...

Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results

... 35,425 32,500 trade accounts receivable, net 16,489 ... and stockholders' equity Current liabilities: trade accounts payable $ 6,751 ... (407) Changes in assets and liabilities: trade accounts receivable 3,875 ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... Oncology. *Editors Note: The FDA has provisionally approved the trade name Prolia(TM) for the proposed indications of treatment and prevention ... undergoing hormone ablation for prostate or breast cancer. The Prolia(TM) trade name is only for these indications and may not apply for other indications ...

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases

... Oncology. *Editors Note: The FDA has provisionally approved the trade name Prolia(TM) for the proposed indications of treatment and prevention ... administered twice yearly subcutaneously at a 60 mg dose. The Prolia(TM) trade name is only for these indications and may not apply for other indications ...

Duska Therapeutics Completes Corporate Name Change to Cordex Pharma

... Stock to trade under new ticker symbol 'CDXP.OB' LA JOLLA, Calif., Jan. 28 ... As a result of the name change, the Over-the-Counter Bulletin Board will trade the Company's common stock under the ticker symbol OTCBB: CDXP.OB. ...

Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials

... team will investigate the potential of simvastatin (marketed under the trade name Zocor), a drug currently used to treat high cholesterol, to reduce ... a Phase 2 study to determine whether isradipine (marketed under the trade name Dynacirc), an approved high blood pressure medication, can rescue ...

Wild Blueberries Take Top Spot in New Antioxidant Research Study

... of North America The Wild Blueberry Association of North America is a trade association of growers and processors of Wild Blueberries from Maine and ... Blueberry health story and unique Wild Advantages to consumers and the trade worldwide. To learn more about Wild Blueberries visit ...

New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy

... anti-epileptic agents.(2,3,4) Zebinix(TM) is one of the proposed EU trade names for eslicarbazepine acetate. In addition, treatment with ... References (1). Zebinix(TM) is one of the proposed EU trade names for Eslicarbazepine acetate (2). Elger C, Halasz P, Maia J et al. ...

GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)

... on Form 20-F for 2007. Notes to Editors: Rezonic(TM), the proposed trade name for casopitant in the United States, is a trademark of the GlaxoSmithKline group of companies in the United States. Zunrisa(TM), the proposed trade name for casopitant, is a trademark of the GlaxoSmithKline group of ...

Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs

... assets 23,046 3,787 Current assets trade receivables 2,224 2,142 Government ... 17 Finance lease 10 17 trade payables 13,858 6,188 Deferred ...

New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target

... expeditiously and stop intimidating countries that use flexibilities in trade law. -- National governments: Build local and regional drug ... WHO drug prequalification process, and use flexibilities in international trade rules to secure the lowest possible drug prices. About the ...

Inhaled Steriods Used as Preventive Treatment Post 9/11

... function of the treated group, as well. "In situations like the World trade Center collapse, significant exposure and symptoms are both risk factors ... illness continues to plague those who were present when the World trade Center collapsed," said Alvin V. Thomas, MD, FCCP, President of the ...

ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells

... About Radilex(TM) and Viprovex(R) Radilex(TM) is the trade name used in referring to formulations of Homspera(TM) for potential indications for treatment of exposure to ionizing radiation. Viprovex(R) is the trade name used in referring to formulations of Homspera(TM) for potential ...

Tainted Chinese Food Ingredients First Discovered in 2005

... Israelsen, executive director of the United Natural Products Alliance, a trade organization representing many of the world's leading dietary supplement ... Future' award and Nutraceuticals World, a leading nutraceutical industry trade magazine, selected TSI in June as a 'company to watch' in ingredient ...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

... Other non-cash transactions 56 (309) Changes in assets and liabilities: Decrease (increase) in trade accounts receivable 2,362 9,570 Decrease (increase) in inventory (791) ...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

... and currency exchange rate fluctuations and volatility in the credit and financial markets; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

... +1 212 830 2456 Isabella Zinck +41 61 324 7188 e-mail: investor.relations@novartis.com * Tekturna(R) is the US trade name for aliskiren. Aliskiren is known as Rasilez(R) outside the US. ...

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)

... partial-onset seizures in adults with epilepsy, and the NDA is currently under formal review. Notes to Editors * Zebinix(R) is the EU trade name for eslicarbazepine acetate. ** European Territories Austria, Belgium, Bulgaria, Czech Republic, Belarus, Bosnia, ...

Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries

... of companies with a focus on the development of prescription drugs that target unmet medical needs, announced that Salvacyl(R) (also known under the trade names Moapar(R) and Salvapar(R)), was launched in Germany in May 2009, by Dr R. Pfleger GmbH. In April 2009, Salvacyl(R) was also launched on a ...

HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens

... $18 billion. "Over ten years," he pointed out, "that is more than double what the PhRMA program seeks to achieve." The HCPC is a not-for-profit trade association that was formed in 1990 to promote the many benefits of unit dose packaging. The United States is one of only a few countries in the ...

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

... sclerosis complex (TSC) and NHL. The active ingredient in Afinitor is everolimus, which is available in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first approved in the EU in 2003. ...

New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer

... and currency exchange rate fluctuations and volatility in the credit and financial markets; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other ...

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

... severe acute pain in patients 18 years of age or older. Tapentadol IR tablets have been approved in 50-mg, 75-mg and 100-mg doses. The FDA-approved trade name for tapentadol is NUCYNTA(TM) (pronounced 'new-sinn-tah'), and the U.S. Drug Enforcement Agency has placed tapentadol into Schedule II of the ...

Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System

... at Research & Development Center, Terumo Corporation, in Japan as a part of a Japanese National Project funded by the Ministry of International trade and Industry. The project was moved from Japan to Ann Arbor, Michigan for product realization in 2000. The first human clinical trial was launched in ...

Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies

... proteins combined with their genomic and clinical information derived from human blood and cancer tissue studies. OGAP(R) is a registered trade mark of Oxford BioTherapeutics Ltd. For further information, please see http://www.OxfordBioTherapeutics.com or http://www.oxbt.co.uk ...

New Study Shows Probiotic Strain Effective in Boosting Immune Response to Flu Virus

... viral exposure indicates a heightened immunological effect to protect against infection. Bacillus coagulans GBI-30, PTA-6086 is marketed under the trade name Ganeden BC30 in various dietary supplements, medical foods, and fortified packaged foods. Swine flu, a variant of influenza A, has ...

Transcept Pharmaceuticals to Report First Quarter 2009 Results

... FDA approval; physician or patient reluctance to use Intermezzo(R) , if approved; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in, clinical development, obtaining ...

Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study

... . ev3, the ev3 logo, SilverHawk and SpiderFX are trademarks of ev3 Inc., registered in the U.S. and other countries. All trademarks and trade names referred to in this press release are the property of their respective owners. Forward Looking Statements Statements contained in ...

Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients

... results to regulators as pivotal studies. Clevudine was licensed from Bukwang Pharmaceuticals of South Korea, where the drug is marketed under the trade name Levovir. "While we are obviously disappointed with the outcome, we believe the decision to stop dosing is an appropriate one," stated ...

Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth

... as the November 2004 issue of Good Housekeeping Magazine. Lexington is a proud member of "Team Florida" and has participated in high-level, overseas trade missions with Governor Jeb Bush. Additionally, the company was awarded by the U.S. Department of Commerce for "Commercial and Export Achievement." ...

Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase

... and providers and personalized health support at www.harvardpilgrim.org . About CAQH CAQH, a nonprofit alliance of health plans and trade associations, is a catalyst for healthcare industry collaboration on initiatives that streamline healthcare administration, resulting in a better ...

Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib

... and non-Hodgkin's lymphoma(11). The active ingredient in Afinitor is everolimus, which is available in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first approved in the EU in 2003. ...

ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance

... ingredient that ViroPharma believes contributes to important performance characteristics of the product that is maintained by ViroPharma as a trade secret. If this inactive ingredient is not present in generic versions of Vancocin, ViroPharma believes those products would fail OGD's proposed ...

CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency

... virus inactivation and removal for safety assurance. There have been more than 1 million units sold worldwide (marketed outside the U.S. under the trade name Haemocomplettan(R) P). CSL Behring is studying RiaSTAP in an ongoing post-marketing commitment study to further demonstrate safety and ...

Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal

... research, including Journal of Laparoendoscopic & Advanced Surgical Techniques and Journal of Gynecologic Surgery . Its biotechnology trade magazine, Genetic Engineering & Biotechnology News ( GEN ) , was the first in its field and is today the industry's most widely read ...

RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments

... available for oncology indications. The active ingredient in RAD001 is everolimus, which is available in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first approved in the EU in 2003. ...

NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology

... the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in, clinical development, obtaining ...

Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse

... a non-invasive Molecular Imaging technique for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and Lung Inflammatory diseases under the trade name PulmoBind. The company was conceived within the Montreal Heart Institute "MHI" (a world renowned hospital and educational facility). ...
Other Contents
(Date:12/22/2014)... 2014 Research and Markets ... of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... of the global digital media watermarking and ... monitor piracy by securely and invisibly embedding ...
(Date:12/19/2014)... DUBLIN , Dec. 18, 2014 Research ... announced the addition of the "iPhone 5S ... Technology Report" report to their offering. ... Following the acquisition of AuthenTec in July 2012, ... iPhone 5S. It is currently the only device ...
(Date:12/19/2014)...  23andMe, Inc., the leading personal genetics company, today ... differences in genetic ancestry of individuals from across ... immigrants first arrived more than four hundred years ago, ... as a meeting place for peoples from different continents. ... mixing of peoples with African, European, and American origins ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
(Date:12/24/2014)... 2014 The report “Stivarga (Colorectal Cancer) ... the current treatment landscape, unmet needs, current pipeline and ... a drug which is used in the treatment of ... and is also prescribed to patients who suffer from ... approved is a multi-kinase inhibitor and it blocks many ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, 2014 (HealthDay News) ... one year will be allowed to donate blood in the United ... ban on donations from men who have sex with men. ... release a new draft guidance in early 2015 that would ultimately ... FDA is changing its policy based on data from other countries ...
(Date:12/24/2014)... WEDNESDAY, Dec. 24, 2014 (HealthDay News) -- A new, ... Food and Drug Administration. The agency on Tuesday ... for those who are overweight and have at least ... type 2 diabetes or high cholesterol. Patients taking ... a low-calorie diet and exercise regularly, the FDA noted. ...
(Date:12/24/2014)... Tara Haelle HealthDay Reporter ... are more likely to start smoking or drinking with ... (ADHD) or conduct disorder, new research suggests. ... the risk of substance use as [these] children approach ... at Cincinnati Pediatric Research Group, which is part of ...
(Date:12/24/2014)... Gluten, a protein found predominately in wheat ... intolerance to gluten, causing side effects that can range ... pain and fatigue. For this reason, Diet Doc created ... safe and fast weight loss while teaching patients how ... reaction. These gluten free diet plans combine the healthiest ...
Breaking Medicine News(10 mins):Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 3
Other TagsOther Tags